germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
IF: 5,179<br />
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
Douillard JY, Rosell R, De L<strong>en</strong>a M, Carpagnano F, Ramlau R, Gonzales‐Larriba JL, Grodzki T, Pereira JR, Le<br />
Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal‐Cortes A, Jassem<br />
J,Koubkova L, His P, Riggi M, Hurteloup P.<br />
Adjuvant vinorelbine plus cisplatin versus observation in pati<strong>en</strong>ts with completely resected stage IB‐IIIA non‐small<br />
cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.<br />
LANCET ONCOL 2006 Sep;7(9):719‐27<br />
IF: 10,119<br />
Felip E, Rosell R.<br />
Clinical experi<strong>en</strong>ce with erlotinib in non‐small‐cell lung cancer.<br />
DRUGS TODAY 2006; 42(3):147‐156.<br />
IF: 1,503<br />
Gamez C, Rosell R, Fernan<strong>de</strong>z A, Andia E, Arnaiz MD, Card<strong>en</strong>al F, Lor<strong>en</strong>zo C.<br />
PET/CT fusion scan in lung cancer: Curr<strong>en</strong>t recomm<strong>en</strong>dations and innovations.<br />
J THORAC ONCOL 2006; 1(1):74‐77.<br />
IF: 0<br />
Juarez A, Camps C, Sirera R, Llobat L, Safont MJ, Berrocal A, Blasco A, Gar<strong>de</strong> J, Munoz‐Navarro M, Taron M, Rosell<br />
R.<br />
Analysis of nerve growth factor (NGF) blood levels in pati<strong>en</strong>ts with advanced non‐small cell lung cancer (NSCLC): Its<br />
correlation with clinical outcome.<br />
LUNG CANCER‐J IASLC 2006; 52:S23‐S23.<br />
IF: 3,554<br />
Lopez‐Pousa A, Losa R, Martin J, Maurel J, Fra J, Sierra M, Casado A, <strong>de</strong>l Muro JG, Poveda A, Balana C, Martinez‐<br />
Trufero J, Esteban E, Buesa JM.<br />
Phase I/II trial of doxorubicin and fixed dose‐rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS<br />
study.<br />
BRIT J CANCER 2006; 94(12):1797‐1802.<br />
IF: 4,459<br />
Plas<strong>en</strong>cia C, Martinez‐Balibrea E, Martinez‐Cardus A, Quinn DI, Abad A, Neamati N.<br />
Expression analysis of g<strong>en</strong>es involved in oxaliplatin response and <strong>de</strong>velopm<strong>en</strong>t of oxaliplatin‐resistant HT29 colon<br />
cancer cells.<br />
INT J ONCOL 2006; 29(1):225‐235.<br />
IF: 2,556<br />
Raz DJ, He B, Rosell R, Jablons DM.<br />
Curr<strong>en</strong>t concepts in bronchioloalveolar carcinoma biology.<br />
CLIN CANCER RES 2006; 12(12):3698‐3704.<br />
IF: 6,177<br />
Raz DJ, He B, Rosell R, Jablons DM.<br />
Bronchioloalveolar carcinoma: a review.<br />
Clin Lung Cancer 2006;7:313‐22<br />
IF:<br />
Rosell R, Cecere F, Cognetti F, Cuello M, Sanchez JM, Taron M, Reguart N, Jablons D.<br />
Pàgina 70/177
Change language